Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of Bilirubin Molecular Species in Patients With Liver Cirrhosis Who Develop Hepatic Encephalopathy and Patients With Acute-on-chronic Liver Failure

NCT05566548 is registered in ClinicalTrials.gov with Medica Sur Clinic & Foundation as lead sponsor.

NCT NCT05566548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of Bilirubin Molecular Species in Patients With Liver Cirrhosis Who Develop Hepatic Encephalopathy and Patients With Acute-on-chronic Liver Failure
Lead sponsor
Medica Sur Clinic & Foundation
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
August 1, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-on-chronic liver failure, hepatic encephalopathy